IF(1): setting the pace of the F(1)F(o)-ATP synthase
- PMID: 19559621
- DOI: 10.1016/j.tibs.2009.03.006
IF(1): setting the pace of the F(1)F(o)-ATP synthase
Abstract
When mitochondrial function is compromised and the mitochondrial membrane potential (Deltapsi(m)) falls below a threshold, the F(1)F(o)-ATP synthase can reverse, hydrolysing ATP to pump protons out of the mitochondrial matrix. Although this activity can deplete ATP and precipitate cell death, it is limited by the mitochondrial protein IF(1), an endogenous F(1)F(o)-ATPase inhibitor. IF(1), therefore, preserves ATP at the expense of Deltapsi(m). Despite a wealth of detailed knowledge on the biochemistry of the interaction of IF(1) and the F(1)F(o)-ATPase, little is known about its physiological activity. Emerging research suggests that IF(1) has a wider ranging impact on mitochondrial structure and function than previously thought.
Similar articles
-
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase.Nat Cell Biol. 2011 Sep 18;13(10):1224-33. doi: 10.1038/ncb2330. Nat Cell Biol. 2011. PMID: 21926988 Free PMC article.
-
Structures and interactions of proteins involved in the coupling function of the protonmotive F(o)F(1)-ATP synthase.Curr Protein Pept Sci. 2002 Aug;3(4):451-60. doi: 10.2174/1389203023380558. Curr Protein Pept Sci. 2002. PMID: 12370007 Review.
-
Inhibition of the mitochondrial ATPase function by IF1 changes the spatiotemporal organization of ATP synthase.Biochim Biophys Acta Bioenerg. 2021 Jan 1;1862(1):148322. doi: 10.1016/j.bbabio.2020.148322. Epub 2020 Oct 14. Biochim Biophys Acta Bioenerg. 2021. PMID: 33065099 Free PMC article.
-
Regulatory mechanisms of proton-translocating F(O)F (1)-ATP synthase.Results Probl Cell Differ. 2008;45:279-308. doi: 10.1007/400_2007_043. Results Probl Cell Differ. 2008. PMID: 18026702 Review.
-
Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1.Cell Metab. 2008 Jul;8(1):13-25. doi: 10.1016/j.cmet.2008.06.001. Cell Metab. 2008. PMID: 18590689
Cited by
-
The mitochondrial ATP synthase as an ATP consumer-a surprising therapeutic target.EMBO J. 2023 May 15;42(10):e114141. doi: 10.15252/embj.2023114141. Epub 2023 Apr 6. EMBO J. 2023. PMID: 37021792 Free PMC article.
-
F1Fo adenosine triphosphate (ATP) synthase is a potential drug target in non-communicable diseases.Mol Biol Rep. 2023 Apr;50(4):3849-3862. doi: 10.1007/s11033-023-08299-3. Epub 2023 Jan 30. Mol Biol Rep. 2023. PMID: 36715790
-
The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1.Biochimie. 2013 Jun;95(6):1258-65. doi: 10.1016/j.biochi.2013.01.019. Epub 2013 Feb 8. Biochimie. 2013. PMID: 23402912 Free PMC article.
-
Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells.Blood. 2012 Aug 9;120(6):1246-53. doi: 10.1182/blood-2011-12-399063. Epub 2012 Jul 2. Blood. 2012. PMID: 22753871 Free PMC article.
-
The F1Fo-ATPase inhibitor protein IF1 in pathophysiology.Front Physiol. 2022 Aug 4;13:917203. doi: 10.3389/fphys.2022.917203. eCollection 2022. Front Physiol. 2022. PMID: 35991181 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous